Cite
HARVARD Citation
Kang, Z. et al. (2012). Activating Death Receptor DR5 as a Therapeutic Strategy for Rhabdomyosarcoma. ISRN oncology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kang, Z. et al. (2012). Activating Death Receptor DR5 as a Therapeutic Strategy for Rhabdomyosarcoma. ISRN oncology. p. . [Online].